Literature DB >> 8548329

Amino acid sequence requirements for the incorporation of the Vpx protein of simian immunodeficiency virus into virion particles.

I W Park1, J Sodroski.   

Abstract

To investigate the amino acid sequence determinants for the incorporation of Vpx protein into virion particles, several mutations were introduced into the vpx gene of SIVmac239 proviral DNA, and the effects of mutations on the expression and assembly of the Vpx protein were studied. The results show that deletions of amino acids from 78 to 80 or from 82 to 87 abolished the incorporation of the expressed Vpx protein into virion particles. Other Vpx mutants, including a full-length Vpx-Vpr fusion protein and a mutant with a deletion of the C-terminal polyproline tract, were packaged efficiently. This study suggests that amino acids from 78 to 80 and 82 to 87 are important for the assembly of the Vpx protein into virus particles.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8548329

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  11 in total

1.  The C-terminal proline-rich tail of human immunodeficiency virus type 2 Vpx is necessary for nuclear localization of the viral preintegration complex in nondividing cells.

Authors:  H A Pancio; N Vander Heyden; L Ratner
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Human immunodeficiency virus type 2 Vpx-Gag interaction.

Authors:  H A Pancio; L Ratner
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  Functional analysis of the simian immunodeficiency virus Vpx protein: identification of packaging determinants and a novel nuclear targeting domain.

Authors:  S Mahalingam; B Van Tine; M L Santiago; F Gao; G M Shaw; B H Hahn
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

4.  Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1.

Authors:  Tommy E White; Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Sarah Amie; Laura Nguyen; Baek Kim; Jurgen Brojatsch; Felipe Diaz-Griffero
Journal:  Virology       Date:  2012-11-13       Impact factor: 3.616

5.  The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation.

Authors:  Tommy E White; Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Sarah Amie; Laura Anh Nguyen; Baek Kim; Marina Tuzova; Felipe Diaz-Griffero
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

6.  Effects of human SAMHD1 polymorphisms on HIV-1 susceptibility.

Authors:  Tommy E White; Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Caitlin Knowlton; Baek Kim; Sara L Sawyer; Felipe Diaz-Griffero
Journal:  Virology       Date:  2014-05-29       Impact factor: 3.616

7.  A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

Authors:  K A Reimann; J T Li; R Veazey; M Halloran; I W Park; G B Karlsson; J Sodroski; N L Letvin
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

8.  Role of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac.

Authors:  Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Tommy E White; Nadine Laguette; Monsef Benkirane; Jurgen Brojatsch; Felipe Diaz-Griffero
Journal:  Retrovirology       Date:  2012-06-12       Impact factor: 4.602

9.  SAMHD1-Dependent and -Independent Functions of HIV-2/SIV Vpx Protein.

Authors:  Mikako Fujita; Masako Nomaguchi; Akio Adachi; Masami Otsuka
Journal:  Front Microbiol       Date:  2012-08-10       Impact factor: 5.640

10.  Contribution of oligomerization to the anti-HIV-1 properties of SAMHD1.

Authors:  Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Tommy E White; Laura Nguyen; Akash Bhattacharya; Zhonghua Wang; Borries Demeler; Sarah Amie; Caitlin Knowlton; Baek Kim; Dmitri N Ivanov; Felipe Diaz-Griffero
Journal:  Retrovirology       Date:  2013-11-12       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.